Atlas Trials

Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856

Clinical trial NCT05783830 · COMPLETED

Trial details

NCT number
NCT05783830
Sponsor
AlzeCure Pharma
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Cognition DisorderAlzheimer Disease
Start date
2020-01-13
Primary completion
2020-04-18
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.